Literature DB >> 1540036

Idiopathic myositis: a rheumatological view.

M R Ehrenstein1, M L Snaith, D A Isenberg.   

Abstract

Twenty five patients with idiopathic myositis attended this department for long term follow up from 1980 to 1989. Twelve patients had primary polymyositis (four men, eight women) and six had primary dermatomyositis (three men, three women); five women had an overlap syndrome. Two patients had a malignant condition associated with the myositis. The mean age at diagnosis was 40 years. All of the patients had proximal muscle weakness, 18/25 had a raised creatine kinase value (mean 2325 IU/l), 19/20 had an abnormal electromyogram, and 19/24 had positive muscle biopsy samples. Of the disease specific antibodies, anti-Jo-1 was detected in only 1/21 patients tested (three patients with fibrosing alveolitis were negative for this antibody), but the 56 kDa antibody was detected in 12/17 patients. The HLA data analysed in the white patients (17/25) showed that 6/8 of those tested were HLA-DR3 positive. All patients were treated with prednisolone and azathioprine was used for 14/25 patients. Only three deaths occurred during the eight year follow up, but there was a substantial morbidity, which may reflect the referral pattern. Muscle strength tests and creatine kinase levels were useful in recording the response to treatment in some patients. These data emphasise that careful long term follow up of patients with myositis is mandatory and that although the present treatment strategy has substantially reduced the death rate, morbidity associated with the disease remains a major problem.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1540036      PMCID: PMC1004616          DOI: 10.1136/ard.51.1.41

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  18 in total

1.  Autoantibodies against a nuclear 56 kDa protein: a marker for inflammatory muscle disease.

Authors:  H Arad-Dann; D Isenberg; E Ovadia; Y Shoenfeld; J Sperling; R Sperling
Journal:  J Autoimmun       Date:  1989-12       Impact factor: 7.094

2.  Ten-year follow-up study of patients with Yersinia arthritis.

Authors:  M Leirisalo-Repo; H Suoranta
Journal:  Arthritis Rheum       Date:  1988-04

3.  Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis.

Authors:  A Bohan; J B Peter; R L Bowman; C M Pearson
Journal:  Medicine (Baltimore)       Date:  1977-07       Impact factor: 1.889

4.  The epidemiology of polymyositis.

Authors:  T A Medsger; W N Dawson; A T Masi
Journal:  Am J Med       Date:  1970-06       Impact factor: 4.965

Review 5.  Adult onset polymyositis/dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature.

Authors:  M C Hochberg; D Feldman; M B Stevens
Journal:  Semin Arthritis Rheum       Date:  1986-02       Impact factor: 5.532

6.  Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system.

Authors:  M Nishikai; M Reichlin
Journal:  Arthritis Rheum       Date:  1980-08

7.  Polymyositis: its presentation, morbidity and mortality.

Authors:  R DeVere; W G Bradley
Journal:  Brain       Date:  1975-12       Impact factor: 13.501

8.  An immunohistological study of secondary Sjögren's syndrome.

Authors:  D A Isenberg; D Rowe; A Tookman; A Hopp; M Griffiths; E Paice; J Stewart; P C Beverley
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

9.  Autoantibodies against a specific nuclear RNP protein in sera of patients with autoimmune rheumatic diseases associated with myositis.

Authors:  H Arad-Dann; D A Isenberg; Y Shoenfeld; D Offen; J Sperling; R Sperling
Journal:  J Immunol       Date:  1987-04-15       Impact factor: 5.422

10.  The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis.

Authors:  S Yoshida; M Akizuki; T Mimori; H Yamagata; S Inada; M Homma
Journal:  Arthritis Rheum       Date:  1983-05
View more
  4 in total

1.  Concomitant diseases in a cohort of patients with idiopathic myositis during long-term follow-up.

Authors:  K P Ng; F Ramos; S M Sultan; D A Isenberg
Journal:  Clin Rheumatol       Date:  2009-04-23       Impact factor: 2.980

2.  Autoimmune chronic active hepatitis and polymyositis in a patient with myasthenia gravis and thymoma.

Authors:  K F Ko; T Ho; K W Chan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-11       Impact factor: 10.154

3.  Clinical, electrophysiologic, and histopathologic profile, and outcome in idiopathic inflammatory myositis: An analysis of 68 cases.

Authors:  K N Ramesha; Abraham Kuruvilla; P S Sarma; V V Radhakrishnan
Journal:  Ann Indian Acad Neurol       Date:  2010-10       Impact factor: 1.383

4.  Development of myasthenia gravis 8 years after interstitial lung disease associated with antisynthetase (anti-EJ antibody) syndrome.

Authors:  Takashi Ishiguro; Naho Kagiyama; Eriko Kawate; Kyuto Odashima; Yotaro Takaku; Kazuyoshi Kurashima; Noboru Takayanagi
Journal:  Clin Case Rep       Date:  2016-12-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.